With Breast Cancer Rates Rising in Connecticut, RCCA Oncologists Offer Insights and Advice
Breast cancer rates are rising across the nation and in Connecticut, with the American Cancer Society estimating that 3,620 women
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Breast cancer rates are rising across the nation and in Connecticut, with the American Cancer Society estimating that 3,620 women
The recently approved therapies target dozens of different cancers and work in a wide variety of ways
HER2-positive and triple-negative breast cancer are among the most aggressive forms of breast cancer and traditionally have had lower survival
Non-Hodgkin lymphoma is a cancer that affects the immune system. Some research indicates that exposure to glyphosate, a common ingredient
An estimated 8,580 women across New Jersey will be diagnosed with breast cancer this year. That number reflects a significant
What if there was a safe, painless, and quick screening test that could reduce the number of lung cancer deaths
Two medical oncologists with Regional Cancer Care Associates LLC (RCCA), one of the nation’s largest networks of cancer specialists, recently
Cancer can affect anyone from any background. However, some racial and ethnic groups have higher rates of certain kinds of
Infusion therapy is a treatment modality that administers medications intravenously. While most people associate infusions with cancer treatment, several different
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.